Glucocorticoid induced diabetes and lipid profiles disorders amongst lymphoid malignancy survivors

Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma

“… 25 The sample size needs to be increased to further evaluate the relationship between the two.Compared with the secondary hyperglycemia group, the primary hyperglycemia group had a worse prognosis. The consideration of secondary hyperglycemia may be related to the application of hormones, 26 excluding weight factors: This study found that compared with the non-hyperglycemia group, the secondary hyperglycemia had a higher BMI, indicating that overweight people are more likely to have secondary hyperglycemia, which in turn affects the prognosis of DLBCL people. So in the process of diagnosis and treatment, we need to pay attention to the weight management of overweight people.Through retrospective analysis, Anil showed that metformin combined with first-line chemotherapy can improve PFS and OS in diabetic patients, preclinical studies had shown metformin had the potential to re-sensitize drug-resistant lymphoma to chemoimmunotherapy.…”

High-density lipoprotein cholesterol and multiple myeloma: A systematic review and meta-analysis

“…1 ). Upon database search, we identified 49 records and finally, 14 studies met the inclusion criteria [ [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] ]. Excluded studies [ 7 , 11 , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] ] together with the reasons of exclusion, are shown in Supplementary Table S1 .…”

“…Out of them, 11 studies were retrospective, while 3 were prospective. Specifically, 3 studies were conducted in Turkey [ 16 , 17 , 28 ] 2 were conducted in France [ 19 , 20 ], 2 in Iran [ 15 , 18 ], 2 in China [ 26 , 27 ], 2 in Poland [ 23 , 24 ], and the rest took place in Brazil, Israel, and the U.S [ 21 , 22 , 25 ]. In total, they included 17,677 participants, 895 of which were MM patients.…”